biotech · Hypertriglyceridemia · Candidiasis, Chronic Mucocutaneous · MTNB
Matinas BioPharma Holdings
Matinas BioPharma Holdings trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Bedminster, USA HQ
2011 Founded
16 Employees
Public company Type
MTNB · NYSE Ticker
Company details
- Status
- Public
- HQ
- Bedminster, USA
- Founded
- 2011
- Employees
- 16
- Programs
- 9
- Drugs
- 5
- Patents
- 8
Matinas BioPharma Holdings clinical trials
Registry index of 10 ClinicalTrials.gov studies linked to Matinas BioPharma Holdings programs — each row shows trial ID, program name, phase, status, and indication.
Matinas BioPharma Holdings trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Matinas BioPharma Holdings.
-
Oral Encochleated Amphotericin B (CAMB) — Phase 2
Clinical update -
Oral Encochleated Amphotericin B (CAMB) — Phase 2
Clinical update -
Oral Encochleated Amphotericin B (CAMB) — Phase 2
Clinical update -
Omega 3 pentaenoic acid — Phase 2
Clinical update -
Placebo — Phase 3
Clinical update -
MAT2203 — Phase 3
Clinical update -
Amphotericin B — Phase 2
Clinical update -
Drug Omega 3 — Phase 2
Clinical update